AAAAAA

   
Results: 1-16 |
Results: 16
LONG-TERM OUTCOME AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA
Authors: DEEG HJ LEISENRING W STORB R NIMS J FLOWERS MED WITHERSPOON RP SANDERS J SULLIVAN KM
Citation: Hj. Deeg et al., LONG-TERM OUTCOME AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA, Blood, 91(10), 1998, pp. 3637-3645
THE DEVELOPMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE - AN ANALYSIS OFSCREENING STUDIES AND THE IMPACT OF CORTICOSTEROID USE AT 100 DAYS AFTER TRANSPLANTATION
Authors: WAGNER JL FLOWERS MED LONGTON G STORB R SCHUBERT M SULLIVAN KM
Citation: Jl. Wagner et al., THE DEVELOPMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE - AN ANALYSIS OFSCREENING STUDIES AND THE IMPACT OF CORTICOSTEROID USE AT 100 DAYS AFTER TRANSPLANTATION, Bone marrow transplantation, 22(2), 1998, pp. 139-146
NOCARDIOSIS AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE STUDY
Authors: VANBURIK JA HACKMAN RC NADEEM SQ HIEMENZ JW WHITE MH FLOWERS MED BOWDEN RA
Citation: Ja. Vanburik et al., NOCARDIOSIS AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE STUDY, Clinical infectious diseases, 24(6), 1997, pp. 1154-1160
USE OF INTERFERON-ALPHA-2A TO TREAT CYTOGENETIC RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER MARROW TRANSPLANTATION
Authors: HIGANO CS CHIELENS D RASKIND W BRYANT E FLOWERS MED RADICH J CLIFT R APPELBAUM F
Citation: Cs. Higano et al., USE OF INTERFERON-ALPHA-2A TO TREAT CYTOGENETIC RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER MARROW TRANSPLANTATION, Blood, 90(7), 1997, pp. 2549-2554
CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING UNRELATED DONOR TRANSPLANTATION
Authors: MORTON AJ ANASETTI C GOOLEY T FLOWERS MED DEEG HJ HANSEN JA MARTIN PJ SULLIVAN KM
Citation: Aj. Morton et al., CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING UNRELATED DONOR TRANSPLANTATION, Blood, 90(10), 1997, pp. 2623-2623
LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN
Authors: STORB R LEISENRING W ANASETTI C APPELBAUM FR BUCKNER CD BENSINGER WI CHAUNCEY T CLIFT RA DEEG HJ DONEY KC FLOWERS MED HANSEN JA MARTIN PJ SANDERS KM WITHERSPOON RP
Citation: R. Storb et al., LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN, Blood, 89(10), 1997, pp. 3890-3891
GRAFT-VERSUS-HOST REACTIONS - ANTILEUKEMIA EFFECTS OF DONOR T-CELLS
Authors: FLOWERS MED SULLIVAN KM DEEG HJ
Citation: Med. Flowers et al., GRAFT-VERSUS-HOST REACTIONS - ANTILEUKEMIA EFFECTS OF DONOR T-CELLS, Transplantation proceedings, 28(3), 1996, pp. 1184-1185
MARROW TRANSPLANTATION FOR FANCONI-ANEMIA - CONDITIONING WITH REDUCEDDOSES OF CYCLOPHOSPHAMIDE WITHOUT RADIATION
Authors: FLOWERS MED ZANIS J PASQUINI R DEEG HJ RIBEIRO R LONGTON G MEDEIROS CR DONEY K SANDERS J BRYANT E HANSEN J SULLIVAN KM APPELBAUM F THOMAS ED STORB R
Citation: Med. Flowers et al., MARROW TRANSPLANTATION FOR FANCONI-ANEMIA - CONDITIONING WITH REDUCEDDOSES OF CYCLOPHOSPHAMIDE WITHOUT RADIATION, British Journal of Haematology, 92(3), 1996, pp. 699-706
ALLOGENEIC MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA ASSOCIATED WITHDYSKERATOSIS-CONGENITA
Authors: LANGSTON AA SANDERS JE DEEG HJ CRAWFORD SW ANASETTI C SULLIVAN KM FLOWERS MED STORB R
Citation: Aa. Langston et al., ALLOGENEIC MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA ASSOCIATED WITHDYSKERATOSIS-CONGENITA, British Journal of Haematology, 92(3), 1996, pp. 758-765
INCIDENCE OF PERIPHERAL NEUROPATHY (PN) PRIOR TO THALIDOMIDE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)
Authors: FLOWERS MED TAPSCOTT SJ EMERSON J EMERSON MV REAGAN T TAYLOR L AJER T SIADAK M SANDERS J ZWINGENBERGER K WILLSMANN K APPELBAUM F SULLIVAN KM
Citation: Med. Flowers et al., INCIDENCE OF PERIPHERAL NEUROPATHY (PN) PRIOR TO THALIDOMIDE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 88(10), 1996, pp. 2423-2423
RESULTS OF 4 REGIMES OF SALVAGE TREATMENT OF REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)
Authors: SULLIVAN KM FLOWERS MED NIMS J LEISENRING W SIADAK M WITHERSPOON R DEEG HJ SANDERS J ANASETTI C THOMPSON D APPELBAUM FR STORB R
Citation: Km. Sullivan et al., RESULTS OF 4 REGIMES OF SALVAGE TREATMENT OF REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 88(10), 1996, pp. 2564-2564
QUALITY-OF-LIFE AS SELF-REPORTED BY 1452 BONE-MARROW TRANSPLANT RECIPIENTS SPANNING 24 YEARS
Authors: CAMPBELL J SULLIVAN KM LEISENRING W NIMS J FLOWERS MED DEEG HJ SIADAK M ERNE K BUSH N APPELBAUM FR STORB R
Citation: J. Campbell et al., QUALITY-OF-LIFE AS SELF-REPORTED BY 1452 BONE-MARROW TRANSPLANT RECIPIENTS SPANNING 24 YEARS, Blood, 86(10), 1995, pp. 2467-2467
OSTEOMYELITIS AND SEPTIC ARTHRITIS DEVELOPING LATE AFTER MARROW TRANSPLANTATION
Authors: MEGASON GC SULLIVAN KM NIMS J FLOWERS MED BOWDEN R APPELBAUM FR STORB R
Citation: Gc. Megason et al., OSTEOMYELITIS AND SEPTIC ARTHRITIS DEVELOPING LATE AFTER MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3820-3820
SPONTANEOUS FACTOR-VIII INHIBITOR OCCURRING IN ASSOCIATION WITH CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: SEIDLER CW MILLS LE FLOWERS MED SULLIVAN KM
Citation: Cw. Seidler et al., SPONTANEOUS FACTOR-VIII INHIBITOR OCCURRING IN ASSOCIATION WITH CHRONIC GRAFT-VERSUS-HOST DISEASE, American journal of hematology, 45(3), 1994, pp. 240-243
PREDICTORS OF THE DEVELOPMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) 100 DAYS AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS RECEIVING METHOTREXATE AND CYCLOSPORINE PROPHYLAXIS
Authors: WAGNER JL FLOWERS MED SULLIVAN KM LONGTON G STORB R
Citation: Jl. Wagner et al., PREDICTORS OF THE DEVELOPMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) 100 DAYS AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS RECEIVING METHOTREXATE AND CYCLOSPORINE PROPHYLAXIS, Blood, 84(10), 1994, pp. 10000540-10000540
DISCONTINUATION OF CYCLOSPORINE (CSP) TO INDUCE A GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT IN PATIENTS WITH CYTOGENETIC RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: FLOWERS MED CLIFT R SCHOCH G SULLIVAN K MARTIN P
Citation: Med. Flowers et al., DISCONTINUATION OF CYCLOSPORINE (CSP) TO INDUCE A GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT IN PATIENTS WITH CYTOGENETIC RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 84(10), 1994, pp. 10000540-10000540
Risultati: 1-16 |